Summary by Moomoo AI
Shanghai Fustar Pharmaceuticals convened the Board of Directors on March 26, 2024 to repurchase the company's shares through a centralized tender transaction and announced the details on the Shanghai Stock Exchange website the next day. Pursuant to the relevant provisions, the Company announces the holding status of the top 10 shareholders and the top 10 unrestricted offer shareholders as of March 26, 2024. OF THESE, SHANGHAI FUSTAR HIGH TECHNOLOGY (GROUP) LIMITED IS THE LARGEST SHAREHOLDER WITH A SHAREHOLDING OF 33.17% AND HKSCC NOMINEES LIMITED HOLDING 20.63%. The repurchase is designed to enhance shareholder value and demonstrate confidence in the future of the company.